Back to Screener

ALPS Group Inc Ordinary Share (ALPS)

Price$0.71
Momentum ScoreF

Favorite Metrics

Price vs S&P 500 (26W)-61.82%
Price vs S&P 500 (4W)-13.52%
VGM Score19.87
Market Capitalization$118.14M

All Metrics

Indicated Dividend (Annual)$0.00
Price vs S&P 500 (YTD)-26.49%
10-Day Avg Trading Volume0.05M
EPS (Annual)$-0.17
ROI (Annual)5.89%
ROA (Last FY)-26.44%
Cash Flow / Share (Annual)$-0.55
EPS Incl Extra (Annual)$-0.17
Current Ratio (Annual)0.05x
Quick Ratio (Quarterly)0.25x
3-Month Avg Trading Volume0.03M
52-Week High$15.00
EPS Excl Extra (Annual)$-0.17
26-Week Price Return-53.90%
Quick Ratio (Annual)0.04x
13-Week Price Return-20.22%
Total Debt / Equity (Annual)0.09x
Current Ratio (Quarterly)0.25x
Enterprise Value$123.23M
3-Month Return Std Dev84.56%
ROE (Last FY)6.39%
EPS Basic Excl Extra (Annual)$-0.17
Revenue / Share (Annual)$0.00
Year-to-Date Return-18.33%
5-Day Price Return-2.74%
EPS Normalized (Annual)$-0.17
Month-to-Date Return-6.57%
EBITD / Share (Annual)$-0.29
Price vs S&P 500 (13W)-28.48%
Beta-1.58x
52-Week Low$0.56
mGradeF
vgmGradeF
Show chart for

About

ALPS Group Inc operates an integrated biotechnology platform providing medical services and wellness solutions focused on precision and preventive health management. The company offers DNA and mRNA sequencing, cellular therapy, and anti-aging products and services.